Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome

Prostate Cancer Clinical Trial

Official title: Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome, a Pilot Study

Status Active, not recruiting

Clinical Trial Summary

This is a prospective observational cohort study of patients with prostate cancer who have a metabolic syndrome. The study aims to evaluate the role of intermittent fasting (fasting mimicking diet) in these patients. The primary end point is metabolic health and the secondary endpoint is quality of life.

Clinical Trial Description

Cancer is a complex set of conditions which collectively comprise the second biggest cause of death in the western world. In addition, these diseases, along with their various treatments, are associated with significant illness, as well as a host of debilitating symptoms. Two very common problems are cancer fatigue, as well as metabolic changes which can cause much suffering in and of themselves. Patients with advanced cancers, as well as many patients undergoing surgery, radiation therapy as well as chemotherapy all complain of fatigue, to a greater or lesser extent. Many gain or lose weight, and develop associated metabolic changes in uninvolved body systems, which can cause a significant health burden on the patients, as well as the healthcare system as a whole.

Little is known about the mechanisms which underlie these symptoms. Various biologic processes have been implicated including inflammation and other changes in body metabolism. There is urgent need to better understand these processes, which cause so much suffering in cancer patients, so as to potentially develop more effective solutions. ;

Related Conditions & MeSH terms

• Intermittent Fasting
• Metabolic Syndrome
• Prostate Cancer
• Prostatic Neoplasms
• Syndrome

• NCT number: NCT04292041
• Study type: Observational [Patient Registry]
• Source: Galway Clinic
• Status: Active, not recruiting
• Start date: January 15, 2019
• Completion date: June 15, 2020